Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma.

Jiang DK, Sun J, Cao G, Liu Y, Lin D, Gao YZ, Ren WH, Long XD, Zhang H, Ma XP, Wang Z, Jiang W, Chen TY, Gao Y, Sun LD, Long JR, Huang HX, Wang D, Yu H, Zhang P, Tang LS, Peng B, Cai H, Liu TT, Zhou P, Liu F, Lin X, Tao S, Wan B, Sai-Yin HX, Qin LX, Yin J, Liu L, Wu C, Pei Y, Zhou YF, Zhai Y, Lu PX, Tan A, Zuo XB, Fan J, Chang J, Gu X, Wang NJ, Li Y, Liu YK, Zhai K, Zhang H, Hu Z, Liu J, Yi Q, Xiang Y, Shi R, Ding Q, Zheng W, Shu XO, Mo Z, Shugart YY, Zhang XJ, Zhou G, Shen H, Zheng SL, Xu J, Yu L.

Nat Genet. 2013 Jan;45(1):72-5. doi: 10.1038/ng.2483. Epub 2012 Dec 16.

2.

Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci of STAT4 and HLA-DQ in a Korean population.

Kim LH, Cheong HS, Namgoong S, Kim JO, Kim JH, Park BL, Cho SW, Park NH, Cheong JY, Koh I, Shin HD, Kim YJ.

Infect Genet Evol. 2015 Jul;33:72-6. doi: 10.1016/j.meegid.2015.04.013. Epub 2015 Apr 22.

PMID:
25913043
3.

Genetic variations in STAT4,C2,HLA-DRB1 and HLA-DQ associated with risk of hepatitis B virus-related liver cirrhosis.

Jiang DK, Ma XP, Wu X, Peng L, Yin J, Dan Y, Huang HX, Ding DL, Zhang LY, Shi Z, Zhang P, Yu H, Sun J, Lilly Zheng S, Deng G, Xu J, Liu Y, Guo J, Cao G, Yu L.

Sci Rep. 2015 Nov 5;5:16278. doi: 10.1038/srep16278.

4.

Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.

Ji X, Zhang Q, Li B, Du Y, Yin J, Liu W, Zhang H, Cao G.

Infect Genet Evol. 2014 Dec;28:201-9. doi: 10.1016/j.meegid.2014.09.032. Epub 2014 Oct 2.

PMID:
25281206
5.

Association of HLA-DP/DQ and STAT4 polymorphisms with HBV infection outcomes and a mini meta-analysis.

Liao Y, Cai B, Li Y, Chen J, Tao C, Huang H, Wang L.

PLoS One. 2014 Nov 3;9(11):e111677. doi: 10.1371/journal.pone.0111677. eCollection 2014.

6.

Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development.

Hu L, Zhai X, Liu J, Chu M, Pan S, Jiang J, Zhang Y, Wang H, Chen J, Shen H, Hu Z.

Hepatology. 2012 May;55(5):1426-31. doi: 10.1002/hep.24799. Epub 2012 Mar 16.

PMID:
22105689
7.

A trivial role of STAT4 variant in chronic hepatitis B induced hepatocellular carcinoma.

Clark A, Gerlach F, Tong Hv, Hoan NX, Song le H, Toan NL, Bock CT, Kremsner PG, Velavan TP.

Infect Genet Evol. 2013 Aug;18:257-61. doi: 10.1016/j.meegid.2013.05.025. Epub 2013 Jun 6.

PMID:
23748017
8.

Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci in a Chinese population.

Chen K, Shi W, Xin Z, Wang H, Zhu X, Wu X, Li Z, Li H, Liu Y.

PLoS One. 2013 Oct 28;8(10):e77315. doi: 10.1371/journal.pone.0077315. eCollection 2013.

9.

Hepatitis B virus genotype, mutations, human leukocyte antigen polymorphisms and their interactions in hepatocellular carcinoma: a multi-centre case-control study.

Wen J, Song C, Jiang D, Jin T, Dai J, Zhu L, An J, Liu Y, Ma S, Qin N, Liang C, Chen J, Jiang Y, Yang L, Liu J, Liu L, Geng T, Chen C, Jiang J, Chen J, Zhu F, Zhu Y, Yu L, Shen H, Zhai X, Xu J, Hu Z.

Sci Rep. 2015 Nov 16;5:16489. doi: 10.1038/srep16489.

10.

Association of HLA-DP/DQ, STAT4 and IL-28B variants with HBV viral clearance in Tibetans and Uygurs in China.

Liao Y, Cai B, Li Y, Chen J, Ying B, Tao C, Zhao M, Ba Z, Zhang Z, Wang L.

Liver Int. 2015 Mar;35(3):886-96. doi: 10.1111/liv.12643. Epub 2014 Aug 5.

PMID:
25041342
11.

Genetic polymorphism of HLA-DQ confers susceptibility to hepatitis B virus-related hepatocellular carcinoma: a case-control study in Han population in China.

Gao X, Liu W, Zhang X, Tang L, Wang L, Yan L, Yang H, Li T, Yang L, Ma N, Liu D.

Tumour Biol. 2016 Sep;37(9):12103-12111. Epub 2016 May 21.

PMID:
27209411
12.

GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers.

Li S, Qian J, Yang Y, Zhao W, Dai J, Bei JX, Foo JN, McLaren PJ, Li Z, Yang J, Shen F, Liu L, Yang J, Li S, Pan S, Wang Y, Li W, Zhai X, Zhou B, Shi L, Chen X, Chu M, Yan Y, Wang J, Cheng S, Shen J, Jia W, Liu J, Yang J, Wen Z, Li A, Zhang Y, Zhang G, Luo X, Qin H, Chen M, Wang H, Jin L, Lin D, Shen H, He L, de Bakker PI, Wang H, Zeng YX, Wu M, Hu Z, Shi Y, Liu J, Zhou W.

PLoS Genet. 2012;8(7):e1002791. doi: 10.1371/journal.pgen.1002791. Epub 2012 Jul 12.

13.

Single Nucleotide Polymorphisms in STAT3 and STAT4 and Risk of Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B.

Chanthra N, Payungporn S, Chuaypen N, Piratanantatavorn K, Pinjaroen N, Poovorawan Y, Tangkijvanich P.

Asian Pac J Cancer Prev. 2015;16(18):8405-10.

14.

Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.

Li S, Deng Y, Chen ZP, Huang S, Liao XC, Lin LW, Li H, Peng T, Qin X, Zhao JM.

Infect Genet Evol. 2011 Dec;11(8):2083-8. doi: 10.1016/j.meegid.2011.09.025. Epub 2011 Oct 12.

PMID:
22019522
15.

STAT4 gene polymorphism and risk of chronic hepatitis B-induced hepatocellular carcinoma.

Zhao X, Jiang K, Liang B, Huang X.

Cell Biochem Biophys. 2015 Jan;71(1):353-7. doi: 10.1007/s12013-014-0205-0.

PMID:
25178516
16.

Mutational complex genotype of the hepatitis B virus X /precore regions as a novel predictive marker for hepatocellular carcinoma.

Jang JW, Chun JY, Park YM, Shin SK, Yoo W, Kim SO, Hong SP.

Cancer Sci. 2012 Feb;103(2):296-304. doi: 10.1111/j.1349-7006.2011.02170.x. Epub 2012 Jan 19.

17.

Variants identified by hepatocellular carcinoma and chronic hepatitis B virus infection susceptibility GWAS associated with survival in HBV-related hepatocellular carcinoma.

Li C, Bi X, Huang Y, Zhao J, Li Z, Zhou J, Zhang M, Huang Z, Zhao H, Cai J.

PLoS One. 2014 Jul 2;9(7):e101586. doi: 10.1371/journal.pone.0101586. eCollection 2014.

18.
19.

KIR and HLA loci are associated with hepatocellular carcinoma development in patients with hepatitis B virus infection: a case-control study.

Pan N, Jiang W, Sun H, Miao F, Qiu J, Jin H, Xu J, Shi Q, Xie W, Zhang J.

PLoS One. 2011;6(10):e25682. doi: 10.1371/journal.pone.0025682. Epub 2011 Oct 5.

20.

[Association between HLA-DQ gene polymorphisms and different outcomes of hepatitis B virus infection].

Liu W, Zhang X, Gao X, Yang L, Li B, Liu D.

Zhonghua Liu Xing Bing Xue Za Zhi. 2016 Mar;37(3):384-8. doi: 10.3760/cma.j.issn.0254-6450.2016.03.019. Chinese.

PMID:
27005542

Supplemental Content

Support Center